The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Vaccine Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Covid-19 Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Covid-19 Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Covid-19 Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DNA segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Covid-19 Vaccine include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, and GlaxoSmithKine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Covid-19 Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Market segment by Application, can be divided into
Adults
Children
Market segment by players, this report covers
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Covid-19 Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Covid-19 Vaccine, with revenue, gross margin and global market share of Covid-19 Vaccine from 2019 to 2022.
Chapter 3, the Covid-19 Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Covid-19 Vaccine market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Covid-19 Vaccine research findings and conclusion, appendix and data source.
Geographical Area
Global
The Covid-19 Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Covid-19 Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Covid-19 Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DNA segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Covid-19 Vaccine include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, and GlaxoSmithKine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Covid-19 Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Market segment by Application, can be divided into
Adults
Children
Market segment by players, this report covers
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Covid-19 Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Covid-19 Vaccine, with revenue, gross margin and global market share of Covid-19 Vaccine from 2019 to 2022.
Chapter 3, the Covid-19 Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Covid-19 Vaccine market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Covid-19 Vaccine research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Covid-19 Vaccine
1.2 Classification of Covid-19 Vaccine by Type
1.2.1 Overview: Global Covid-19 Vaccine Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Covid-19 Vaccine Revenue Market Share by Type in 2021
1.2.3 DNA
1.2.4 Non-replicating Viral Vector
1.2.5 Protein Subunit
1.2.6 RNA
1.2.7 Others
1.3 Global Covid-19 Vaccine Market by Application
1.3.1 Overview: Global Covid-19 Vaccine Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Covid-19 Vaccine Market Size & Forecast
1.5 Global Covid-19 Vaccine Market Size and Forecast by Region
1.5.1 Global Covid-19 Vaccine Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Covid-19 Vaccine Market Size by Region, (2017-2022)
1.5.3 North America Covid-19 Vaccine Market Size and Prospect (2017-2028)
1.5.4 Europe Covid-19 Vaccine Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Covid-19 Vaccine Market Size and Prospect (2017-2028)
1.5.6 South America Covid-19 Vaccine Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Covid-19 Vaccine Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Covid-19 Vaccine Market Drivers
1.6.2 Covid-19 Vaccine Market Restraints
1.6.3 Covid-19 Vaccine Trends Analysis
2 Company Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna Covid-19 Vaccine Product and Solutions
2.1.4 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Moderna Recent Developments and Future Plans
2.2 CanSino Biologicals
2.2.1 CanSino Biologicals Details
2.2.2 CanSino Biologicals Major Business
2.2.3 CanSino Biologicals Covid-19 Vaccine Product and Solutions
2.2.4 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 CanSino Biologicals Recent Developments and Future Plans
2.3 Inovio Pharmaceuticals
2.3.1 Inovio Pharmaceuticals Details
2.3.2 Inovio Pharmaceuticals Major Business
2.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions
2.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Inovio Pharmaceuticals Recent Developments and Future Plans
2.4 Shenzhen Geno-Immune Medical Institute
2.4.1 Shenzhen Geno-Immune Medical Institute Details
2.4.2 Shenzhen Geno-Immune Medical Institute Major Business
2.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions
2.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments and Future Plans
2.5 GlaxoSmithKine
2.5.1 GlaxoSmithKine Details
2.5.2 GlaxoSmithKine Major Business
2.5.3 GlaxoSmithKine Covid-19 Vaccine Product and Solutions
2.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKine Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Covid-19 Vaccine Product and Solutions
2.6.4 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Johnson＆Johnson
2.7.1 Johnson＆Johnson Details
2.7.2 Johnson＆Johnson Major Business
2.7.3 Johnson＆Johnson Covid-19 Vaccine Product and Solutions
2.7.4 Johnson＆Johnson Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Johnson＆Johnson Recent Developments and Future Plans
2.8 Heat Biologics
2.8.1 Heat Biologics Details
2.8.2 Heat Biologics Major Business
2.8.3 Heat Biologics Covid-19 Vaccine Product and Solutions
2.8.4 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Heat Biologics Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Covid-19 Vaccine Product and Solutions
2.9.4 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Covid-19 Vaccine Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Covid-19 Vaccine Players Market Share in 2021
3.2.2 Top 10 Covid-19 Vaccine Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Covid-19 Vaccine Players Head Office, Products and Services Provided
3.4 Covid-19 Vaccine Mergers & Acquisitions
3.5 Covid-19 Vaccine New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Covid-19 Vaccine Revenue and Market Share by Type (2017-2022)
4.2 Global Covid-19 Vaccine Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
5.2 Global Covid-19 Vaccine Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Covid-19 Vaccine Revenue by Type (2017-2028)
6.2 North America Covid-19 Vaccine Revenue by Application (2017-2028)
6.3 North America Covid-19 Vaccine Market Size by Country
6.3.1 North America Covid-19 Vaccine Revenue by Country (2017-2028)
6.3.2 United States Covid-19 Vaccine Market Size and Forecast (2017-2028)
6.3.3 Canada Covid-19 Vaccine Market Size and Forecast (2017-2028)
6.3.4 Mexico Covid-19 Vaccine Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Covid-19 Vaccine Revenue by Type (2017-2028)
7.2 Europe Covid-19 Vaccine Revenue by Application (2017-2028)
7.3 Europe Covid-19 Vaccine Market Size by Country
7.3.1 Europe Covid-19 Vaccine Revenue by Country (2017-2028)
7.3.2 Germany Covid-19 Vaccine Market Size and Forecast (2017-2028)
7.3.3 France Covid-19 Vaccine Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Covid-19 Vaccine Market Size and Forecast (2017-2028)
7.3.5 Russia Covid-19 Vaccine Market Size and Forecast (2017-2028)
7.3.6 Italy Covid-19 Vaccine Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Covid-19 Vaccine Revenue by Type (2017-2028)
8.2 Asia-Pacific Covid-19 Vaccine Revenue by Application (2017-2028)
8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region
8.3.1 Asia-Pacific Covid-19 Vaccine Revenue by Region (2017-2028)
8.3.2 China Covid-19 Vaccine Market Size and Forecast (2017-2028)
8.3.3 Japan Covid-19 Vaccine Market Size and Forecast (2017-2028)
8.3.4 South Korea Covid-19 Vaccine Market Size and Forecast (2017-2028)
8.3.5 India Covid-19 Vaccine Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Covid-19 Vaccine Market Size and Forecast (2017-2028)
8.3.7 Australia Covid-19 Vaccine Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Covid-19 Vaccine Revenue by Type (2017-2028)
9.2 South America Covid-19 Vaccine Revenue by Application (2017-2028)
9.3 South America Covid-19 Vaccine Market Size by Country
9.3.1 South America Covid-19 Vaccine Revenue by Country (2017-2028)
9.3.2 Brazil Covid-19 Vaccine Market Size and Forecast (2017-2028)
9.3.3 Argentina Covid-19 Vaccine Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Covid-19 Vaccine Revenue by Type (2017-2028)
10.2 Middle East & Africa Covid-19 Vaccine Revenue by Application (2017-2028)
10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country
10.3.1 Middle East & Africa Covid-19 Vaccine Revenue by Country (2017-2028)
10.3.2 Turkey Covid-19 Vaccine Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Covid-19 Vaccine Market Size and Forecast (2017-2028)
10.3.4 UAE Covid-19 Vaccine Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Covid-19 Vaccine Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Covid-19 Vaccine Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Covid-19 Vaccine Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Covid-19 Vaccine Revenue (USD Million) by Region (2017-2022)
Table 5. Global Covid-19 Vaccine Revenue Market Share by Region (2023-2028)
Table 6. Moderna Corporate Information, Head Office, and Major Competitors
Table 7. Moderna Major Business
Table 8. Moderna Covid-19 Vaccine Product and Solutions
Table 9. Moderna Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. CanSino Biologicals Corporate Information, Head Office, and Major Competitors
Table 11. CanSino Biologicals Major Business
Table 12. CanSino Biologicals Covid-19 Vaccine Product and Solutions
Table 13. CanSino Biologicals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. Inovio Pharmaceuticals Major Business
Table 16. Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions
Table 17. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Shenzhen Geno-Immune Medical Institute Corporate Information, Head Office, and Major Competitors
Table 19. Shenzhen Geno-Immune Medical Institute Major Business
Table 20. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions
Table 21. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKine Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKine Major Business
Table 24. GlaxoSmithKine Covid-19 Vaccine Product and Solutions
Table 25. GlaxoSmithKine Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Covid-19 Vaccine Product and Solutions
Table 29. Pfizer Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Johnson＆Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson＆Johnson Major Business
Table 32. Johnson＆Johnson Covid-19 Vaccine Product and Solutions
Table 33. Johnson＆Johnson Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Heat Biologics Corporate Information, Head Office, and Major Competitors
Table 35. Heat Biologics Major Business
Table 36. Heat Biologics Covid-19 Vaccine Product and Solutions
Table 37. Heat Biologics Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Covid-19 Vaccine Product and Solutions
Table 41. Sanofi Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Covid-19 Vaccine Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Covid-19 Vaccine Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Covid-19 Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Covid-19 Vaccine Players Head Office, Products and Services Provided
Table 46. Covid-19 Vaccine Mergers & Acquisitions in the Past Five Years
Table 47. Covid-19 Vaccine New Entrants and Expansion Plans
Table 48. Global Covid-19 Vaccine Revenue (USD Million) by Type (2017-2022)
Table 49. Global Covid-19 Vaccine Revenue Share by Type (2017-2022)
Table 50. Global Covid-19 Vaccine Revenue Forecast by Type (2023-2028)
Table 51. Global Covid-19 Vaccine Revenue by Application (2017-2022)
Table 52. Global Covid-19 Vaccine Revenue Forecast by Application (2023-2028)
Table 53. North America Covid-19 Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Covid-19 Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Covid-19 Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Covid-19 Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Covid-19 Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Covid-19 Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Covid-19 Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Covid-19 Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Covid-19 Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Covid-19 Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Covid-19 Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Covid-19 Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Covid-19 Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Covid-19 Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Covid-19 Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Covid-19 Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Covid-19 Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Covid-19 Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Covid-19 Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Covid-19 Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Covid-19 Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Covid-19 Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Covid-19 Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Covid-19 Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Covid-19 Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Covid-19 Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Covid-19 Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Covid-19 Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Covid-19 Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Covid-19 Vaccine Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Covid-19 Vaccine Picture
Figure 2. Global Covid-19 Vaccine Revenue Market Share by Type in 2021
Figure 3. DNA
Figure 4. Non-replicating Viral Vector
Figure 5. Protein Subunit
Figure 6. RNA
Figure 7. Others
Figure 8. Covid-19 Vaccine Revenue Market Share by Application in 2021
Figure 9. Adults Picture
Figure 10. Children Picture
Figure 11. Global Covid-19 Vaccine Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Covid-19 Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Covid-19 Vaccine Revenue Market Share by Region (2017-2028)
Figure 14. Global Covid-19 Vaccine Revenue Market Share by Region in 2021
Figure 15. North America Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Covid-19 Vaccine Market Drivers
Figure 21. Covid-19 Vaccine Market Restraints
Figure 22. Covid-19 Vaccine Market Trends
Figure 23. Moderna Recent Developments and Future Plans
Figure 24. CanSino Biologicals Recent Developments and Future Plans
Figure 25. Inovio Pharmaceuticals Recent Developments and Future Plans
Figure 26. Shenzhen Geno-Immune Medical Institute Recent Developments and Future Plans
Figure 27. GlaxoSmithKine Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Johnson＆Johnson Recent Developments and Future Plans
Figure 30. Heat Biologics Recent Developments and Future Plans
Figure 31. Sanofi Recent Developments and Future Plans
Figure 32. Global Covid-19 Vaccine Revenue Share by Players in 2021
Figure 33. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Covid-19 Vaccine Revenue Market Share in 2021
Figure 35. Global Top 10 Players Covid-19 Vaccine Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Covid-19 Vaccine Revenue Share by Type in 2021
Figure 38. Global Covid-19 Vaccine Market Share Forecast by Type (2023-2028)
Figure 39. Global Covid-19 Vaccine Revenue Share by Application in 2021
Figure 40. Global Covid-19 Vaccine Market Share Forecast by Application (2023-2028)
Figure 41. North America Covid-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 42. North America Covid-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 43. North America Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 44. United States Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Covid-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 48. Europe Covid-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 49. Europe Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 50. Germany Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Covid-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Covid-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Region (2017-2028)
Figure 58. China Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Covid-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 65. South America Covid-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 66. South America Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Covid-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Covid-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Covid-19 Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
